One-time gene therapy with four years of effectiveness; New hope for patients with hereditary angioedema.
New data from gene therapy based on CRISPR technology show that its effect remains in some patients with hereditary angioedema up to four years after a single injection; An approach that can reduce dependence on ongoing preventive medications.
Read the full text at the link below.